Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Deferred Taxes (2020 - 2021)

Exagen (XGN) has disclosed Deferred Taxes for 2 consecutive years, with $148000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Deferred Taxes rose 1245.45% year-over-year to $148000.0, compared with a TTM value of $148000.0 through Dec 2021, up 239.62%, and an annual FY2022 reading of -$306000.0, down 306.76% over the prior year.
  • Deferred Taxes was $148000.0 for Q4 2021 at Exagen, up from $11000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $148000.0 in Q4 2021 and bottomed at -$117000.0 in Q1 2020.